Microalbuminuria screening for patients having type 2 diabetes mellitus: Who wants to participate?

Leung, Gabriel M.; Redelmeier, Donald A.; Szalai, John P.; Boyle, Eleanor; Hilditch, John R.; Tobe, Sheldon W.
February 2001
Clinical & Investigative Medicine;Feb2001, Vol. 24 Issue 1, p37
Academic Journal
Conclusions: There is little difference in the prevalence of albuminuria related to patients' willingness to participate in a screening program. Therefore, there are no disproportionate gains for family practice researchers who aggressively seek difficult-to-recruit patients in this setting. In contrast, primary care doctors should make every effort to ensure optimal care to diabetic patients regardless of a patient's initial hesitancy.


Related Articles

  • Response to ‘Renal microvascular and tubular injuries in type II diabetic nephropathy’. Verzola, Daniela; Gandolfo, Maria T.; Ferrario, Franco; Rastaldi, Maria P.; Villaggio, Barbara; Gianiorio, Francesco; Giannoni, Massimo; Rimoldi, Laura; Lauria, Francesca; Mij, Mariano; Deferrari, Giacomo; Garibotto, Giacomo // Kidney International;Aug2008, Vol. 74 Issue 3, p390 

    A response by Daniela Verzola and colleagues to a letter to the editor about their article "Renal Microvascular And Tubular Injuries in Type II Diabetic Nephropathy" in the 2008 issue is presented.

  • Renal microvascular and tubular injuries in type II diabetic nephropathy. Futrakul, Narisa; Futrakul, P. // Kidney International;Aug2008, Vol. 74 Issue 3, p390 

    A letter to the editor is presented in response to the article "Renal Microvascular And Tubular Injuries in Type II Diabetic Nephropathy," by Daniela Verzola and colleagues in the 2008 issue.

  • Disease profile: diabetic nephropathy. Popat, Reena J. // Journal of Renal Nursing;2012, Vol. 4 Issue 2, p78 

    The article presents an overview of diabetic nephropathy, which significantly impacts morbidity and mortality of people with diabetes. It is one of the leading causes of end-stage kidney disease worldwide. The key clinical features of diabetic nephropathy include persistent albuminuria,...

  • Dear Readers. Grzeszczak, Władysław // Experimental & Clinical Diabetology / Diabetologia Doswiadczalna;2011, Vol. 11 Issue 2, preceding p45 

    An introduction is presented to several reports within the issue on topics including insulin therapy for type 2 diabetics treated with oral medications, diagnosis of kidney hyperfiltration using serum cystatin C, and newly diagnosed diabetes with metabolic syndrome and absolute insulin deficiency.

  • Application of the guidelines for the request of microalbuminuria in diabetic patients. Lukic, V. // Biochemia Medica;2014 Supplement, Vol. 24, pS68 

    Background: Microalbumiuria is defined as excretion of 30-300 mg of albumin/24 h. American Diabetes Association and National Kidney Foundation guidelines, but also Serbian clinical guidelines for diabetes, emphasise significance of microalbuminuria determination in diabetic patients because of...

  • The risk factors of diabetic nephropathy in Taiwan, including old age, hypertension and aspirin therapy. Cheng, Yu-Wen; Malik, Usman; Chang, Shih-Liang // International Journal of Diabetes in Developing Countries;Jun2013, Vol. 33 Issue 2, p128 

    A letter to the editor is presented in response to the article "The risk factors of diabetic nephropathy in Taiwan, including old age, hypertension and aspirin therapy," by Yu-Wen Cheng et al., in the May 21, 2013 issue.

  • Update in nephrology. Goldfarb, Stanley; Henrich, William L.; Goldfarb, S; Henrich, W L // Annals of Internal Medicine;01/01/98, Vol. 128 Issue 1, p49 

    Gives information on the renal disease in diabetics. Identification of the types of renal diseases; Comparison of the effects of antihypertensive agents on the kidney; Prediction of nephropathy in type 2 diabetes.

  • Erratum.  // Kidney & Blood Pressure Research;2019, Vol. 44 Issue 4, p878 

    Assessment of renal pathology, tubular damage score, the expression of MIOX, Sirt1 and ROS generation in patients with DN. A notable increase in MIOX expression and ROS production was seen in the kidneys of DN patients compared to the control (b vs. a and f vs. e). In contrast, the expression of...

  • Quantitation of microalbuminuria using random urine samples. Asadi, Frank K. // Pediatric Nephrology;Feb2002, Vol. 17 Issue 2, p107 

    Abstract Microalbuminuria is a harbinger of progressive renal disease and cardiovascular complications in patients with diabetes mellitus. The method most commonly used to measure microalbuminuria relies on a timed urine collection, either a 24-h or overnight specimen, which is...


    The article presents an answer to a question related to screening for microalbuminuria in patients with diabetic nephropathy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics